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ABSTRACT 
Productivity Studies Utilizing Recombinant CHO Cells In Stirred-Tank Bioreactors:  A 
Comparative Study Between The Pitch-Blade And The Packed-Bed Bioreactor Systems 
by 
Taylor S. Hatton, Master of Science 
Utah State University, 2012 
Major Professor: Dr. Kamal A. Rashid, Ph.D. 
Department: Animal, Dairy and Veterinary Sciences 
A recombinat Chinese Hamster Ovary (rCHO) cell line designated as CHO SEAP 
was utilized in this investigation to optimize protein production. Two bench top stirred-
tank bioreactors, namely a pitched-blade and a packed-bed basket bioreactor, were 
utilized for a comparative study to determine which bioreactor would produce the best 
results in terms of protein production.  The objective of this research project was to 
provide basic data that shows cells cultured in a packed-bed basket bioreactor in 
perfusion mode will generate more protein product than cells in batch mode suspension 
culture with a pitched-blade bioreactor.  The packed-bed bioreactor creates a homeostatic 
environment similar to the environment found in vivo, where waste products are 
constantly removed and fresh nutrients are replenished.  Closed batch cultures do not 
provide a homeostatic environment. In batch culture systems, nutrients are depleted and 
waste products accumulate.  The results from this experiment could help investigators 
involved in protein and/or vaccine  production facilities select the appropriate bioreactor 
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and mode of operation to optimize cell productivity for generation of a specific protein 
product.  CHO cells have been used for the production of vaccines, recombinant 
therapeutic proteins, and monoclonal antibodies, and these cells are now the cell line of 
choice in the biopharmaceutical industry.  Traditional vaccine production methods in egg 
embryos are slow and outdated, whereas roller bottle-based cell culture techniques are 
time consuming and have limited scalability.  These limitations justify the need for 
development of stirred tank bioreactors.   Cells cultured in a packed-bed bioreactor are 
not exposed to hydrodynamic forces, as is the case with pitched-blade bioreactors, 
allowing for maximum growth and protein expression.   This mode of operation involves 
the constant removal of media depleted of nutrients and the addition of fresh media with 
more nutrients to keep the cells growing. Long run times decrease the constant need for 
re-seeding cells and re-establishing seed cultures, thus, reducing setup time and labor 
dramatically.  Secreted products are automatically separated from cells in perfusion, 
eliminating filtration and membrane fouling.  A detailed description of both modes of 
operation are discussed in this thesis. 
(74 Pages) 
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PUBLIC ABSTRACT 
Productivity Studies Utilizing Recombinant CHO Cells In Stirred-Tank Bioreactors:  A 
Comparative Study Between The Pitch-Blade And The Packed-Bed Bioreactor Systems 
by 
Taylor S. Hatton, Master of Science 
The Center for Integrated Biosystems (CIB) at Utah State University proposed to 
demonstrate the added benefits of bench top stirred-tank bioreactors utilizing the packed-
bed impeller system in perfusion mode for the production of recombinant proteins.  In 
this study recombinant Chinese Hamster Ovary (CHO) cells were utilized for the 
production of a secreted protein in two bioreactor types: pitched-blade bioreactor 
operated in batch mode versus packed-bed bioreactor operated in perfusion mode.   Our 
primary objective was to determine whether the packed-bed bioreactor is superior to a 
traditional pitched-blade bioreactor for the mass production of cell culture protein 
products.  We hypothesize that the reduced culture stress and optimal growth conditions 
of the packed-bed basket system will result in a higher yield of protein product compared 
to the traditional pitched-blade system. 
The pitched-blade impeller is commonly used for the growth of shear sensitive 
animal cells.  The impeller provides gentle mixing of the media without damaging the 
cells.  The packed-bed basket impeller is composed of two metal perforated screens.  In-
between the screens are Fibra-Cel disks which create a bed to which suspension cells are 
entrapped.  Cells cultured in a packed-bed bioreactor are growing in a shear free 
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environment as they are not exposed to hydrodynamic forces allowing for maximum 
growth and protein expression.   
Three independent experiments were performed in each bioreactor system 
described.  The results from these experiments could help investigators involved in 
protein and/or vaccine  production facilities select the appropriate bioreactor and mode of 
operation to optimize cell productivity for a specific protein product.  
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LIST OF SYMBOLS, NOTATIONS AND DEFINITIONS 
Symbol Key 
C  Celsius 
g  Gram 
L  Liter 
mL  Milliliter 
mm  Millimeter 
mM  Micromolar 
µL  Micro-Liter 
µmol  Micro-mol 
U  Unit 
Abbreviation Key 
ALKP   Alkaline phosphatase 
CIAP  Calf intestinal alkaline phosphatase 
CO2  Carbon dioxide 
DO  Dissolved oxygen 
IPTG  Isopropyl β-D-1-thiogalactopyranoside 
PBS  Phosphate buffer solution 
PLAP  Placental alkaline phosphatase 
pNPP  p-nitrophenylphosphate 
rCHO  Recombinant Chinese Hamster Ovary 
RTD  Resistance temperature detector 
SEAP  Secreting alkaline phosphatase 
Definitions 
Unit (U): The amount of enzyme that hydrolyzes 1 µmol if p-nitrophenylphosphate to p-
nitrophenol in a total reaction volume of 1 mL in 1 minute at 37ºC. 
Batch Culture: A closed system in which cells are grown in a fixed volume of culture 
media under specific environmental conditions, such as temperature, agitation, and 
aeration, until a certain density is reached or for a set time frame.  The cells are then 
harvested and processed as a batch, usually before all nutrients are depleted.  
Perfusion Culture: An open system in which cells are maintained in the bioreactor either 
by a cell retention device inside the vessel or by filtration, sedimentation, or 
centrifugation of the cells.  Such devices or methods allow for nutrient solutions to be fed 
into the system and for spent media with toxic byproducts to be removed.
  
CHAPTER 1 
INTRODUCTION 
 Animal cell culture began in the late 19th century.  In 1885, German zoologist 
Wilhelm Roux maintained the neural plate from a chicken embryo in a warm saline 
solution for several days, an accomplishment not yet obtained by the scientific elite of the 
day [1].  In the early 1900s, American Scientist Ross Harrison succeeded in maintaining 
amphibian nerve fibers in conditions suitable for proliferation of the fibers.  Harrison 
placed disaggregated fragments of frog tissue in coagulated frog lymph and later 
observed outgrowths of new nerve cells from the tissue.  Harrison’s work laid the 
foundation for modern cell culture and aroused the interest of leading scientists of the 
period [2].  Rous and Jones were the first scientists to use trypsin, a proteolytic enzyme, 
to make unicellular suspensions of cells in culture [3].  Alexis Carrel introduced the next 
major advancement in cell culture, the Carrel flask, which was the precursor to the 
modern T-flask.  Carrel was also the first cell culturist to demonstrate that animal cells 
could be grown without the use of antibiotics.  Carrel’s complex sterile techniques and 
Carrel flask helped reduce contamination and increased tissue handling [4].  Early work 
in cell culture relied on undefined media as the source of nutrients.  Albert Fischer was 
the first to develop a defined media for cell culture, CMRL 1066, which he developed in 
1948 [5].  In 1956, Harry Eagle developed Minimal Essential Medium (MEM), a medium 
still commonly used today [6].  The increased emphasis in chemically defined media and 
aseptic technique helped solidify the future of animal cell culture. 
 Innovations in animal cell culture techniques continued throughout the next 50 
years.  During the 1950’s the first continuously cultured human cell line, HeLa [7] was 
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established from cervical tissue.  Scientists also shifted their focus to development of 
defined media for cell culture, such as Eagle’s Basel Media (BME), Eagle′s Minimum 
Essential Medium (MEM) and CMRL 1066 (Connaught Medical Research Laboratories) 
[8, 9].  These defined media formulations provided researchers the opportunity to utilize 
serum-free cell culture techniques in the 1960s [10], followed by the first sterile plastic 
cell culture vessels and development of many suspension cell lines in the 1970s.  In 1975, 
Kohler and Milstein were the first group of scientists to produce a monoclonal antibody 
(mAb)-secreting hybridoma cell line.  Their discovery set off a revolution in mAb 
production in all areas of basic research [11, 12].  Many specialized cell lines were 
developed in the 1980s, including cell lines for scale-up and production of mAbs.    The 
packed-bed bioreactor and Fibra-Cel disks used in the present study were also developed 
in the 1980s.  The human genome project of the 1990s lead to profiling the transcriptome 
and proteome of many cell lines commonly used in bioprocessing.  The early 21st 
century was the era of omics and stem cell research [8].  As technology continues to 
progress the future is open to many more advances in animal cell culture. 
In recent years, the Chinese hamster ovary (CHO) cell has become an important 
expression system of recombinant proteins for many biopharaceutical companies.  CHO 
cells and two murine myeloma cell lines, NS0 and SP2/0, are currently the three main 
mammalian cell lines which produce FDA approved products.  Of the 21 FDA approved 
products produced by mammalian cells, five were produced using CHO cells [13].  The 
use of recombinant CHO (rCHO) cell lines in stirred-tank bioreactors is becoming a 
method of choice for the scale-up of protein products.  
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Figure 1.  (Left) Packed-bed bioreactor and (right) pitch-blade bioreactor. (With 
permission from NBSC)  
 
 An rCHO cell line designated as CHO SEAP was utilized in this investigation to 
optimize growth conditions, growth parameters and protein production.  The pitched-
blade and packed-bed bioreactors (Figure 1), both bench top stirred-tank bioreactors, 
were utilized for this comparative study to determine which bioreactor would produce the 
best results in terms of protein production. The overall hypothesis for this research 
project was that cells cultured in a packed-bed basket bioreactor in perfusion mode would 
generate more protein product than the cells cultured in the pitched-blade bioreactor in 
batch mode.  The packed-bed bioreactor creates a homeostatic environment similar to the 
environment found in vivo where waste products are constantly removed and fresh 
nutrients are replenished.  Batch cultures do not provide a homeostatic environment due 
to the depletion of nutrients and the accumulation of waste products [14].  The results 
from this experiment could help investigators involved in protein and/or vaccine 
production facilities select the appropriate bioreactor and mode of operation to optimize 
cell productivity for a specific protein product.  
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CHO cells have been used for the production of vaccines, recombinant therapeutic 
proteins and monoclonal antibodies.  These cells are now a cell line of choice in the 
biopharmaceutical industry [15-18].  Traditional vaccine production methods in egg 
embryos are slow and outdated, whereas roller bottle based cell culture techniques are 
time consuming and have limited scalability.  These technological limitations 
demonstrate the need to develop more rapid and scalable methods for vaccine production 
to serve human and livestock populations worldwide.    Suspension cells coupled with 
stirred-tank bioreactors is a technology that will provide large-scale protein and vaccine 
production with less labor and expense.  Two modes of operation in stirred-tank 
bioreactors were investigated in this study: batch and perfusion. A batch culture is a 
closed system in which cells are grown in a fixed volume of culture media under specific 
environmental conditions, such as temperature, agitation,  and aeration, until a certain 
density is reached or for a set time frame.  The cells are then harvested and processed as a 
batch, usually before all nutrients are depleted.  A perfusion culture is an open system in 
which cells are maintained in the bioreactor either by a cell retention device inside the 
vessel or by filtration, sedimentation, or centrifugation of the cells. Such devices or 
methods allow for nutrient solutions to be fed into the system and for spent media with 
toxic byproducts to be removed. 
Cells cultured in a packed-bed bioreactor are not exposed to hydrodynamic forces, 
like pitched-blade bioreactors, thus allowing for maximum growth and protein expression 
[19].   Also, cells in these packed-bed bioreactors may be maintained for weeks or even 
months on a perfusion culture system.   This operation method involves the constant 
removal of media depleted of nutrients and the addition of fresh media with more 
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nutrients to keep the cells growing. Long run times allowed with the packed-bed 
bioreactor decrease the constant need for re-seeding cells and re-establishing seed 
cultures, thus reducing setup time and labor dramatically.  Perfusion techniques also 
allow for higher cell densities, reaching as high as a 5- to 10-fold increase compared with 
batch cultures [20].  The packed-bed bioreactor produces high yields of secreted products 
from all types of animal cells [21].  The entrapped cells avoid shear from impellers, gas 
bubbles and pumps and allow higher mixing speeds, thereby increasing mass transfer of 
nutrients and oxygen.  Secreted products are automatically separated from cells in 
perfusion which eliminates filtration and membrane fouling.  Perfusion techniques in 
pitched-blade bioreactors are cumbersome and complex, usually requiring one of three 
techniques: centrifugation, filtration or sedimentation.  The packed-bed bioreactor 
eliminates the need for all of these techniques as the cells are trapped in-between the 
Fibra-Cel disks allowing for media changes without the loss or damage of cells [22].  
Animal cells lack a cell wall and are therefore vulnerable to shear effects inside 
bioreactors.  Most of the cell damage arises from gas sparging aeration and mechanical 
agitation [23, 24].  Tramper, et al. suggested three areas of a bubble column where cells 
may experience shear stress: bubble formation at the sparger tip, the bubble ascending 
region and bubble disengagement at the gas-liquid interface.  Murhammer, et al., contend 
that the influx of media into the space vacated by detaching bubbles from the sparger is a 
source of hydrodynamic stress deleterious to surrounding cells [25].  Although rising 
bubbles create little shear stress [26], they can lead to cell entrainment [27].  Entrained 
cells are subjected to bubble disengagement at the gas-liquid interface shown in Figure 2 
(next page).  As bubbles burst, high speed liquid jets are created causing hydrodynamic 
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Figure 2.  Bubble disengagement at the gas-liquid intergace.  (A) Bubble rises to the 
surface.  (B) Bubble bursts causing the bubble film to rapidly reced.  (C) The high 
pressure casued by the bubble bursting causes two liguid jets to form, one downward 
into the medium and one upword into the gas headspace. 
stress.  Although the pitched-blade impeller is designed for shear sensitive cells, the 
rotating blade can damage cells at high agitation rates [28].  The rotation creates a vortex 
which may introduce bubbles into the system leading to bubble entrainment.  Additives 
like fetal bovine serum (FBS) and chemicals like Pluronic F68 are effective means of 
protecting cells from hydrodynamic stress [25].  The use of these additives requires their 
removal in any downstream processing.  The packed-bed bioreactor is not subjected to 
the same hydrodynamic forces since the cells are sequestered by the Fibra-Cel disks thus 
eliminating the need for protective agents described above. 
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Packed-bed bioreactors have been compared with microcarrier systems [19], and 
perfusion systems have been compared to fed-batch systems [29, 30]. Perfusion and batch 
cultures are two common modes of operation for scale-up of mammalian cells in culture.  
However, to date, no studies have compared the productivity of protein-secreting cells in 
packed-bed bioreactors in perfusion mode to pitched-blade bioreactors in batch mode. 
Therefore, the primary objective of this study was to determine whether cells cultured in 
a packed-bed bioreactor in perfusion mode would generate more protein product than 
cells cultured in a traditional pitched-blade bioreactor in batch mode.   Cell densities of 
about 5 x 10
5 
cells/mL were used for seeding each bioreactor.   The experimental design 
utilized three separate runs for each bioreactor type for validity and reproducibility.  
Three strategies were implemented to monitor cell yield, viability and protein production.  
Growth of cells in the pitched-blade bioreactor will be measured by offline samples and 
cell count via Trypan Blue staining and the Countess instrument (Invitrogen, Life 
Technologies).  A minor limitation to the packed-bed bioreactor is the inability to obtain 
direct cell counts and viability.  Therefore, cell growth cannot be measured directly in the 
packed-bed bioreactor.  Glucose up-take and lactose production were measured in the 
pitched-blade and packed-bed bioreactors utilizing the YSI 2700 Select Biochemistry 
Analyzer (YSI, Inc., Yellow Springs, OH).  Both instruments are available in the 
bioprocessing facility at the Center for Integrated BioSystems.  Protein concentrations 
were monitored every 24 hours in each bioreactor for the duration of each experiment 
using an enzyme assay (AnaSpec, Freemont, CA).   All offline samples were plotted on a 
graph every 24 hours to monitor the progress of each bioreactor.   We expect that the 
results of this research project will aid in the introduction of packed-bed basket 
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bioreactors in perfusion mode as a desirable and productive approach to mass producion 
of CHO and other cell lines in large scale biopharmaceutical production including animal 
vaccines to keep the sources of the food supplies safe for consumption.   
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Figure 3. Suspension rCHO cells. 
CHAPTER 2 
MATERIALS AND METHODS 
2.1 Cell Line 
The CHO cell line was first establish in 1957 by Dr. Theodor Puck. While at the 
University of Colorado he isolated the cells from the ovary of a female Chinese hamster 
[18].  CHO cells have become a well proven system for the production of proteins 
suitable for human use and therefore all experiments utilized a proprietary recombinant 
CHO cell line provided by CDI Bioscience, Inc. (Madison, WI).  The rCHO cells were 
originally developed from the CHO-S (Invitrogen) cell line.  The rCHO cell line is 
defined by the developer as SEAP (Alkaline Phosphatase secreting) Suspension Cells. 
The rCHO cells were engineered with the IPTG-regulated RP Shift vector so that the 
rCHO cells stop replicating and shift to protein production when induced with IPTG. 
CHO cells carry out many human congruent, post-translational modifications and have an 
inherent resistance to viral infection, making them a choice expression system [31].  
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2.2 Growth Medium 
All experiments utilized CD-CHO medium (Gibco, Life Technologies, Grand 
Island, NY) which is a chemically defined, protein-free medium used for high density 
growth of rCHO cells.  CD-CHO medium is free from any animal origin products, which 
will eliminate any batch to batch variability simplifying any downstream processing and 
reduce cost.  The media contains 6.3g/L glucose and was supplemented with final 
concentrations of 8 mM L-glutamine and 100µg/mL of an antibiotic/antimycotic solution 
(G418).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Metabolic pathways for glucose and glutamine in mammalian cells. (Ref. 
32) 
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2.3 Seed Culture Development 
Frozen stocks of rCHO cells were thawed at 37⁰C then transferred to T-75 flasks 
with CD-CHO serum-free medium and allowed to expand.  Once a sufficient number of 
cells were achieved, sterile disposable spinner flasks were utilized to further expand the 
cells.  The spinner flasks contain a magnetic stirring bar to mix the cell suspension when 
placed on a magnetic stirring plate.  The seeded spinner flasks were then placed on a 
magnetic stirring plate inside a CO2 incubator at 5% CO2 and 37⁰C and allowed to grow 
for two days.  The spinner flasks were then sub-cultured and seeded into new spinner 
flasks and allowed to reach confluency.  Subculture of the cells continued until a 
sufficient number of viable cells was achieved for use as a seed culture at the density of 
approximately 5 x 10
5
 cells/mL. 
 2.4 Bioreactors 
Advanced bench-top stirred-tank bioreactors were utilized to scale up the rCHO 
cells.  The New Brunswick Scientific Company (NBSC) Bioflo 310 bioreactor allows the 
operator to control and monitor many parameters such as dissolved oxygen (DO), pH, 
temperature and impeller speed via a microprocessor control system.  All this is made 
possible with a 15” touch screen which clearly displays all set points, present values, 
loops, cascades and more on the summery or synoptic screens.  The Bioflo 310 can be 
used for batch, fed batch or continuous (perfusion) culturing of cells. Each vessel is 
surrounded by a water jacket and capped with a stainless steel headplate.  The headplate 
has many customizable ports for pH and DO probes, addition and sample ports, sparger, a 
thermowell for a resistance temperature detector (RTD), an exhaust condenser, etc.  The 
vessels are autoclavable for sterilization purposes. The motor attaches to a magnetic drive 
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coupling which is located in the center of the headplate.  The motor ranges in speeds 
from 25 to 500 RPM (+5 rpm). The RTD can detect the temperature inside the vessel 
between 5⁰C above coolant temperature to 80⁰C (+0.1⁰C).  A Gel-filled pH probe can 
sense the pH ranging on the scale from 2-12 (+0.01). The DO electrode has a range of 
control from 0-200% (+1%). 
  
2.4.1 Pitched-Blade Impeller 
For these experiments two different bioreactor systems were utilized.  The first 
bioreactor system utilized the pitched-blade impeller.  The blades on the pitched-blade 
impeller are flat and set at a 45º angle.  This blade orientation gives good axial and radial 
mixture of the media while also increasing the oxygen mass transfer rate and disruption 
of bubbles released from the sparger.  The pitched-blade impeller is designed to minimize 
stress of mixing on shear-sensitive cells [33].  
 
 
Figure 5.  (A) New Brunswick Scientific’s CelliGen 310 bioreactor system.  (B) 
Summary screen shows convenient view set points, current values, cascade loops and 
more.  (With permission from NBSC) 
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2.4.2 Batch Process (Pitched-Blade Bioreactor) 
Three experimental trials were performed using the pitched-blade bioreactor in 
batch mode in a 2.2 L vessel (1.7 L working volume).  The vessel was equipped with a 
pitched-blade as described above.  For each trial, the bioreactor was allowed to operate 
until the cell concentration reached approximately 2 x 10
6 
cells/mL, at which the cells 
were induced with IPTG.  The growth and productivity was documented for the duration 
of the batch experiment.  All of the experimental trials had the following parameters: 
agitation speed set to 120 rpm (+ 5 rpm); dissolved oxygen at 35% (+1%); temperature at 
37°C (+0.1⁰C); and pH at 7.1 (+0.01).   
2.4.3 Packed-Bed Basket Impeller 
The second bioreactor system was equipped with the packed-bed basket impeller. 
This bioreactor system is suitable for both anchorage dependent and suspension cells. 
With this system there is no need to adapt anchorage dependent cells to suspension.  The 
packed-bed basket impeller is commonly used in the production and collection of 
extracellular proteins [21].  The packed-bed basket impeller incorporates a basket with 
two horizontally positioned perforated metal screens.  Fibra-Cel disks are placed in 
between the metal screens creating a bed to entrap suspension cells or provide a surface 
                
Figure 6.  Pitched-blade impeller. 
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for attachment of anchorage dependent cells.  The Fibra-Cel disk bed provides a culture 
environment that allows freshly oxygenated media to slowly pass over the cells while 
also providing protection from external shear forces [33].  The rotation of the impeller 
creates a negative pressure that draws media up through the hollow center shaft where the 
sparger introduces oxygen to the media.  The media flows in a spiral direction from the 
bottom of the vessel up the central shaft and out the three discharge ports at the top.  The 
media then trickles down through the packed cell bed saturating it with nutrients and 
oxygen.  The packed-bed basket bioreactor is the ideal system to use when a product is 
secreted out of the cell.  Because cells immobilized in the Fibra-Cel bed, samples of 
media can easily be removed without the loss of cells or culture disruption.  
 
2.4.4 Fibra-Cel Disks 
The Fibra-Cel disks consist of sheets of polyester and polypropylene 
ultrasonically bonded together and then punched to a diameter of 6mm round disks.  
 
Figure 7.   (A) Packed-bed bioreactor.  (B) Basket apparatus for packed-bed bioreactor.  
(With permission from NBSC) 
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They are then washed in methanol, electrostatically treated and tested for endotoxins, 
cytotoxicity, bioburden and viral degradation.  Fibra-Cel disks create approximately 
1,200cm
2
/g of surface area and are optimized at 100 grams of disks per liter of media.  A 
1.7L working volume bioreactor containing 85g of Fibra-Cel disks creates a total surface 
area of 102m
2
 (335sq. ft.).  The surface created by the Fibra-Cel disks is equivalent to the 
same area available with 120 roller bottles (850cm
2
), 453 t-flasks (225cm
2
) and 4,080 t-
flasks (25cm
2
). 
 
 
2.4.5 Perfusion Process (Packed-Bed Basket Bioreactor) 
Three experimental trials were performed using the packed-basket bioreactor 
operated in perfusion mode in a 2.2 L total volume vessel (1.7 L working volume).  The 
vessel was equipped with a basket, as described above, containing 85g of Fibra-Cel disks. 
The perfusion process was initiated once the cells reached the exponential phase.  Each 
bioreactor was allowed to run for 12 days once perfusion started.  The perfusion process 
utilized in these experiments required the removal of the media from the bioreactors over 
 
 
Figure 8.  (A) Fibra-Cel disks.  (B) High resolution micrograph of a Fibra-Cel disk 
indicating the polyester mesh with polypropylene support.  (With permission from 
NBSC) 
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several minutes.  On day 1 of perfusion, 0.5 L of the media was removed from the vessel 
and replaced with fresh medium using a peristaltic pump.  On day 2 1 L of media 
similarly replaced; subsequently, 2 L of culture media was replaced every other day (up 
to day 15).  The growth and productivity was documented for the duration of the 
perfusion experiment.  Otherwise, all experimental trials had the same growth conditions 
(temperature, oxygen, pH) as the batch process.   
2.5 Project Timeline 
Figure 9 details the timeline followed for each bioreactor system.  The pitched-
blade bioreactor, shown in blue, was seeded with 5 x 10
5
 cells/mL on day zero followed 
with an initial glucose and lactate measurement and initial cell count and viability.   
Glucose and lactate levels were measured and cell count and viability were checked on 
days 1 and 2.  The cells were induced with IPTG on day 3 or 4; depending on when the 
cell density reached 2 x 10
6
 cells/mL.  Glucose and lactate levels, along with cell count 
and viability, were measured pre and post induction and every day thereafter for the 
duration of the experiment.  Each experiment in the pitched-blade bioreactor lasted 
approximately 9 days.  The packed-bed bioreactor, shown in brown, was seeded with 5 x 
10
5
 cells/mL on day zero followed with an initial glucose and lactate measurement. 
Glucose and lactate levels were measured on days 1 and 2.  Day 3 began the perfusion 
process where 0.5L of media was removed from the bioreactor and replaced with fresh 
media.  On day 4 1L of media was replaced. On day 5 and every-other day thereafter, 2L 
(complete volume) of media was replaced with fresh media containing IPTG.  Glucose 
and lactate measurements were taken pre and post perfusion on all three days.  On day 6 
and every-other-day thereafter, glucose and lactate measurements were taken. 
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2.6 Secreted Alkaline Phosphatase (SEAP) 
SEAP is a reporter gene that is used to control the level of protein expression at 
the transcriptional and post-transcriptional levels.  SEAP was created by truncating 
Placental Alkaline Phosphatase (PLAP) at the 489
th
 amino acid by the addition of a 
termination codon.  There are some significant advantages to the truncated form of 
PLAP.  The truncated form liberates PLAP from the cell surface membrane allowing it to 
be secreted.  This truncation also creates a thermally stable protein at 65⁰C.  At this 
temperature other isozymes of alkaline phosphatase will be inactivated.  Both of these 
advantages allow for easy sampling and testing of SEAP [34, 35].  CHO cells have been 
engineered to secrete alkaline phosphatase (ALKP). ALKP’s are naturally occurring 
enzymes found in many body tissues, especially the liver, bone and kidney.  Although 
ALKP’s function is not fully understood, ALKP’s hydrolyze monophosphate esters in 
proteins, nucleotides and other molecules in tissues where they reside [36].   The levels of 
ALKP in the media were measured using a SEAP enzymatic assay and then plotted on a 
graph. 
Day 
0 
Day 
1-2 
Day 
3 
Day 
4 
Day 
5 
Day 
6 
Day 
7-15 
Figure 9.  Established timeline for each bioreactor system.  The pitched-blade bioreactor 
is shown in blue and the packed-bed bioreactor is shown in brown. 
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2.7 SEAP Enzymatic Assay 
The SensoLyte pNPP Secreted Alkaline Phosphatase Reporter Gene Assay 
(AnaSpec, Freemont, CA) is a powerful tool used in the detection of alkaline 
phosphatase.  The gene expression levels of Alkaline Phosphatase can be determined 
with the use of the Alkaline Phosphatase Reporter Gene Assay.  All experimental runs 
were followed by the SEAP Enzymatic Assay and the results from each bioreactor type 
were compared to see which bioreactor allowed for more protein production.  All cell 
free supernatant samples were incubated at 65⁰C for 30 minutes and 125µl of cell free 
supernatant were diluted in 125µl of PBS.  Fifty microliters of the diluted supernatant 
was then inserted into four individual wells per sample of a 96 well plate.  Various 
known dilutions of calf intestinal alkaline phosphatase (CIAP), used as the standard, were 
also added to each plate.  Fifty microliters of a 1:100 solution of pNPP and 2X assay 
buffer were then added to each sample.  The plate was incubated at 37⁰C for 60 minutes 
and then immediately measured on a SpectraMax Plus plate reader at 405nm to determine 
   
      
     1 MLGPCMLLLL LLLGLRLQLS LGIIPVEEEN PDFWNREAAE ALGAAKKLQP AQTAAKNLII 
    61 FLGDGMGVST VTAARILKGQ KKDKLGPEIP LAMDRFPYVA LSKTYNVDKH VPDSGATATA 
   121 YLCGVKGNFQ TIGLSAAARF NQCNTTRGNE VISVMNRAKK AGKSVGVVTT TRVQHASPAG 
   181 TYAHTVNRNW YSDADVPASA RQEGCQDIAT QLISNMDIDV ILGGGRKYMF RMGTPDPEYP 
   241 DDYSQGGTRL DGKNLVQEWL AKRQGARYVW NRTELMQASL DPSVTHLMGL FEPGDMKYEI 
   301 HRDSTLDPSL MEMTEAALRL LSRNPRGFFL FVEGGRIDHG HHESRAYRAL TETIMFDDAI 
   361 ERAGQLTSEE DTLSLVTADH SHVFSFGGYP LRGSSIFGLA PGKARDRKAY TVLLYGNGPG 
   421 YVLKDGARPD VTESESGSPE YRQQSAVPLD EETHAGEDVA VFARGPQAHL VHGVQEQTFI 
   481 AHVMAFAACL EPYTACDLAP PAGTTDAAHP GRSVVPALLP LLAGTLLLLE TATAP 
Figure 10.  PLAP amino acid sequence with truncated SEAP amino acid sequence in black.  
Source: http://www.ncbi.nlm.nih.gov/protein/178476? 
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the endpoint reading. The change in ALKP production from each experiment was plotted 
on a graph and compared between each bioreactor system. 
2.8 Glucose and Lactate Analysis 
The YSI 2700 Select Biochemistry Analyzer (YSI, Inc., Yellow Spring, OH) was 
utilized to check the glucose and lactate levels in the medium every 24 hours for the 
duration of each experiment.  This instrument provides fast and precise analysis of 
nutrients or byproducts in the media. 
2.9 Cell Count and Viability 
The Countess Instrument (Invitrogen, Life Technologies), an automated cell 
counter, was utilized to count viable cells and calculate cell % viability in the pitched-
blade bioreactor.  This instrument uses plastic disposable slides with two enclosed 
chambers.  The counting occurs at the center of these chambers where the total volume 
counted is 0.4µL.  The volume equates to counting four 1 mm x 1 mm squares on a 
standard Hemocytometer.  The Countess comes with a special trypan blue stain to only 
be used with this machine. Conventional cell counting with Hemocytometer and 
microscope will also be used.  
2.10 Growth Curve 
The progress and behavior of the rCHO cells were monitored by developing a 
growth curve.  A growth curve is ideal for determining the correct seeding density that 
will give a short lag period which is the first phase, or the stage directly following a 
subculture.  Cells during this phase are adjusting to the new environment.   There is very 
little growth of cells and sometimes even a loss of cells during this phase is possible.  The 
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second phase is the log or exponential growth phase.  As the name implies there is an 
exponential increase in cell numbers with a growth rate of 90-100%.  This is the optimal 
time for product formation and sampling.   The population doubling time can be 
measured in the middle of the exponential phase.  The third phase is the plateau phase 
where cell proliferation is reduced to 0-10%.  In this phase the culture will reach 
confluency which will give the maximum cell density that can be reached in the vessel. 
Cells for experimental purposes should always be taken from the middle of the log phase 
to the plateau phase.  Several parameters can be measured from the established growth 
curve.  The first parameter is the lag time which is the adaptation time the cells need to 
again reach the initial seeding density in the lag phase.  The second parameter is the 
doubling time which is the time needed for the cells to increase twofold in the middle of 
the exponential phase and subsequent doublings that take place before the cells enter 
senescence or cell death phase.  The third parameter is the saturation density which is 
defined as the maximum number of cells per mL [8].  Seven 60mm tissue culture dishes 
were seeded with 10
4
 cells in 5 mL media.  One dish was counted every other day over a 
14-day period and the points were plotted on a graph. 5 mL of fresh media were added to 
the remaining culture dishes on days 4 and 12.  Cells were spun down on day 8 and 
resuspended in 5 mL of fresh media.  The growth curve helped in selecting the optimal 
time in the exponential phase for induction.  During this stage cells are viable and 
actively dividing. 
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CHAPTER 3 
RESULTS 
3.1 Pitched-Blade Bioreactor Operated in Batch Mode 
3.1.1 Cell Density and Viability 
Figure 11 shows cell growth and viability in three independent experiments in the 
pitched-blade bioreactor.  Seeding densities were 0.29 – 0.57 x 106 cells/mL as calculated 
by trypan blue staining utilizing the Countess cell counter.  A slight decrease in cell 
density occurred in experiments 1 and 2 between days 3 and 4, suggesting that the 
optimal time for induction occurred on day 3.  At the time of induction, cell densities 
were 1.5 x 10
6
 cells/mL in both experiments 1 and 2 (Fig. 11A-B).  The maximum cell 
density observed in experiment 1 (2.7 x 10
6
 cells/mL) was relatively lower than in 
experiment 2 (3.5 x 10
6
 cells/mL).  Due to the rapid exhaustion of glucose in experiment 
3, it was necessary to induce the cells on day 3.  Cell density in experiment 3 was 2.0 x 
10
6
 cells/mL at the time of induction, and the maximum cell density observed was 2.2 x 
10
6
 cells/mL (Fig. 14C).  Cell viability was greater than 90% in all experiment trials with 
the pitched-blade bioreactor. 
3.1.2 Glucose Utilization and Lactate Production 
Glucose is the main energy source for cell proliferation and ALKP production.  
Thus, glucose levels and cell densities were expected to directly correlate with ALKP 
production in each experiment. Because lactate is a secondary energy source, lactate 
levels were expected to decline following this initial increase and the utilization of 
glucose in the media.  Lactate metabolism is beneficial to the system by reducing a major 
metabolic by-product from the system [37, 38]. Glucose levels measured at the time of 
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induction were 2.6 g/L in experiments 1 and 2, while glucose levels measured at the time 
of induction in experiment 3 were nearly depleted at 0.8 g/L (Fig. 12).  Glucose levels in 
the first two experiments were sufficient to sustain ALKP production.  However, glucose 
consumption by the cells in experiment 3 depleted amounts necessary to support the 
production of ALKP.  Lactate levels in experiment 3 were nearly 1.5 g/L higher than the 
previous experiments, suggesting that cell replication may have been inhibited (Fig. 
12C).  Similar results were reported by others using CHO and NSO cells [37].  
3.1.3 ALKP Production 
Figure 13 shows the concentrations of ALKP measured daily or at the time of cell 
harvest in each of the three independent replicated experiments utilizing the pitched-
blade bioreactor.  ALKP concentrations steadily increased over the six culture days post 
induction.  However, a decrease in ALKP activity was observed at the time of harvest in 
trials 2 and 3, possibly due to degradation of the ALKP protein at the end of the 
experiment [39, 40].  Serum free media was utilized for growth of rCHO cells in this 
study.  Thus, ALKP was susceptible to the action of proteases made by the rCHO cells 
[41].  As compared to the first trial, the increased cell density observed in experiment 2 
indicates that cell proliferation was more predominant than the production of ALKP (Fig. 
13).  As reported above, glucose levels and cell density in trial 3 were the lowest of all 
the replicate experiments, and these observations likely account for the low amount of 
ALKP detected. 
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Figure 11.  Growth of rCHO cells in pitched-blade bioreactor system.  Values shown 
are the cell density and viability on each day of culture, and each panel represents an 
independent experiment trial (A, trial 1; B, trial 2; C, trial 3).  The dashed line 
indicates the time of induction of ALKP production by IPTG. 
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Figure 12.  Glucose consumption and lactate production by rCHO cells cultured in 
the pitched-blade bioreactor system.  Values shown are the concentrations of glucose 
and lactate in the culture media measured daily, and each panel represents an 
independent experiment trial (A, trial 1; B, trial 2; C, trial 3).  The dashed line 
indicates the time of induction of ALKP production by IPTG. 
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Figure 13.  ALKP production by rCHO cells cultured in the pitched-blade bioreactor 
system.  (A) ALKP concentration in culture media measured each day of each 
experimental trial.  IPTG induction of ALKP occurred on culture day four for 
experimental trials 1 and 2 and on day three for experiment 3.  (B) Values shown are 
the media ALKP concentrations at time of cell harvest for all three experimental trials; 
also shown is the mean total production of ALKP ± SEM for all three experimental 
trials.  
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3.2 Packed-Bed Bioreactor Operated in Perfusion Mode 
3.2.1 Cell Density and Viability 
The packed-bed bioreactors in all three replicate experiments were seeded with 
5.0 x 10
5
 cells/mL.  However, because of the presence of the Fibra-Cel discs, it was not 
possible to sample the cells directly during culture to determine yield and viability.  
Therefore, cell count and viability were not monitored on a daily basis; rather, the rate of 
glucose consumption was used as a surrogate to approximate changes in cell density [15].  
The growth of cells in the packed-bed reactor was estimated using the average glucose 
consumption rate and rate growth of cells in the pitched-blade bioreactor.  Glucose 
consumption rates were markedly similar in both the pitched-blade and packed-bed 
bioreactor systems up to day 4 (Fig. 14).  However, after day four of culture, glucose 
utilization in the packed-bed bioreactor continued to increase exponentially, while the 
trend for glucose consumption in the pitched-blade bioreactor increased linearly.  
Increased glucose consumption observed on culture day five suggests that cell density in 
the packed-bed bioreactor had likely increased.  
3.2.2 Glucose Utilization and Lactate Production 
Most of the glucose consumption by the cells in experiment 1 was observed prior 
to media exchanges during the perfusion process (Fig. 15A).  Cells in experiment 2 
utilized the least amount of glucose in the media prior to repeat media exchanges (Fig. 
15B), whereas the majority of glucose used by the cells in experiment 3 occurred within 
the first 24 hours after each media exchange (Fig 15C).  As previously observed with the 
pitch-blade bioreactor system, media lactate concentrations increased in response to 
decreasing glucose availability in all three trials (Fig. 15.) 
27 
 
3.2.3 ALKP Production 
Concentrations of ALKP in the three independent experiments utilizing the 
packed-bed bioreactor are shown in Figure 16.  Following initial expansion culture of 
rCHO cells for five days, ALKP production was induced every two days with a media 
exchange containing IPTG.  We determined previously that continuous culture with IPGT 
in the media yielded greater production of ALKP compared to a transient exposure to the 
inducing agent (data not shown).  A modest increase in ALKP production was observed 
at each media exchange, although the level of ALKP varied by induction day and by 
experiment trial (Fig. 16).  The correlation between glucose utilization and ALKP 
production observed previously supports the inference that the rate of glucose 
consumption in experiment 1 and 2 was conducive to the production of moderate 
amounts of ALKP.  However, the pattern of glucose utilization and ALKP was notably 
different in trial 3 (Fig. 16C).  The rapid exhaustion of glucose and a presumed high cell 
density were likely contributing factors to the noticeably greater amounts of ALKP 
observed in experiment 3 compared to the other trials.  
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Figure 14.  Comparison of glucose up-take by rCHO cells in pitched-blade and 
packed-bed bioreactor systems.  Values shown are the mean daily glucose media 
concentrations consumed ± SEM of three replicate experiments. 
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Figure 15.  Glucose consumption and lactate production by rCHO cells cultured in the 
packed-bed bioreactor system.  Values shown are the amounts of glucose and lactate 
measured in the culture media at each media exchange.  The time and volume of the media 
exchange is indicated at each dashed line.  Induction of ALKP activity by IPTG began on 
culture day 5 and continued every two days throughout the remainder of the experiment.  
Results of three experimental trials are shown (A, trial 1; B, trial 2; C, trial 3). 
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Figure 16.  ALKP production by rCHO cells cultured in the packed-bed bioreactor 
system.  (A) ALKP concentration in culture media measured each day of each 
experimental trial.  IPTG induction of ALKP began on culture day five and continued 
every two days for the remainder of the experiment.  (B) Stacked bar charts show the 
cumulative production of ALKP throughout the experiment, with each bar 
representing a perfusion.  Also shown is the mean total production of ALKP ± SEM of 
all three experimental trials.   
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Figure 17.  Comparison of ALKP production by rCHO cells cultured in the pitch-
blade and packed-bed bioreactor systems.  Values shown are the mean ALKP 
concentration ± SEM for three replicate, independent experimental trials using either 
the pitch-blade or packed-bed bioreactor systems. 
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3.3 Comparison of Bioreactor Systems for ALKP Production 
A major objective of this study was to compare the pitched-blade and the packed-
bed bioreactors run in their routine operating modes (batch and perfusion, respectively).  
The average total ALKP production per experiment trial is shown in Figure 17; overall, 
the packed-bed bioreactor system produced ALKP to a much greater extent (nearly 3-fold 
greater) compared to the packed-bed system.  This pattern is retained even when 
accounting for different volumes of culture media used in the two bioreactor systems (1.7 
L for the pitched-blade system compared to 1.3 L for the packed-bed system).  The total 
amount of ALKP measured after five media exchanges in the packed-bed bioreactor was 
10,500 U compared to 4,640 U in the pitched-blade bioreactor, or approximately a 2.25-
fold greater production of ALKP in the packed-bed bioreactor.  
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Figure 18.  Growth curve of CHO-SEAP cells grown in suspension in plastic 60 mm tissue 
culture dishes.  Seven tissue culture dishes were seeded with 10,000 cells.  (A) First four days 
of growth.  (B) Complete growth curve. 
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3.4 Growth Curve Results 
Figure 18 shows results from a 14-day growth curve experiment.  Three groups of 
seven 60mm tissue culture dishes were seeded with 1 x 10
4
 cells in 5 mL media.  One 
dish was counted every other day for 14 days and the total cell count per plate was used 
to plot the growth curve.  Cells were in the Lag phase for a very short period of time as 
the cells quickly started to divide.  Cells quickly entered the Log phase which lasted 
approximately 9 days.  Cells entered the Plateau stage on day 10 reaching a maximum 
density of 1.7 x10
7
 total cells on day 12.  These growth results suggest that days 5 to 7 
were the optimal times for induction.  During this period cells are viable and rapidly 
dividing. 
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CHAPTER 4 
DISCUSSION AND CONCLUSIONS 
Although the bioprocessing industry is currently dominated by the well-proven 
batch culture process, results of this study suggest that a perfusion mode of operation in a 
packed-bed culture environment may prove superior in some applications.  The perfusion 
mode of cell culture offers some significant advantages to large-scale cell producers, such 
as lower set-up and maintenance costs and greater performance [42, 43].  By virtue of its 
design, the packed-bed bioreactor may be used continuously for months at a time when 
operated in perfusion mode.  The limitation of 15 days was for establishing basic data on 
the performance of rCHO cells in the bioreactor for commercial production of 
biopharmaceuticals.  The three-dimensional environment of the Fibra-Cel disks provides 
optimal culture conditions for cell growth and allows for new infusions of media into the 
system without cell loss.  The shear-free culture environment of the packed-bed system 
offers more flexibility for researchers utilizing anchorage-dependent cell lines for the 
production of proteins or vaccines.  Cell line maintenance is reduced since preparation of 
new seed cultures is not required.  Moreover, initial setup effort associated with the 
packed-bed bioreactor is substantially less than would be required using the pitched-blade 
system, which requires multiple, shorter cultures to equal the production of a single 
culture with the packed-bed system.  The perfusion process also offers several 
advantages, such as the removal of toxic metabolites or excreted proteases and the 
infusion of fresh nutrients to maintain optimal culture conditions.  Protein product quality 
is likely to be higher with the perfusion system, as freshly secreted cellular proteins may 
be removed periodically by media exchanges.  In case of products that are highly labile, 
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rapid removal from the packed-bed bioreactor is possible with the perfusion system [39].  
However, a disadvantage of the packed-bed bioreactor is limited scalability.  The packed-
bed system is currently limited to a maximal operating volume of about 100 L, although 
larger scale packed-bed reactors may be available in the future.  Additionally, when 
considering the cost-benefit of the packed-bed system, the cost of Fibra-Cel disks should 
be taken into account. Although this cost is not significant considering the value of the 
protein product. 
Although the pitched-blade bioreactor requires less monitoring over the duration 
of an experiment, as cells are cultured until nutrient depletion has occurred, this approach 
does require significant initial input in terms of labor and resources.  Multiple culture 
runs, and thus multiple seed cultures and system preparations, are required to match the 
output of the packed-bed system.  In addition, application of a perfusion operation mode 
to pitched-blade systems requires pumping the cells through a membrane filtration device 
(e.g., hollow fiber columns) to prevent cell loss [44].  This process can impair bioreactor 
sterility and cause potential damage to the cells.  Finally, cell product concentration may 
be comparatively low, as exemplified in this study, compared to the initial resources 
(volume of culture media) invested in the culture system.  Given these drawbacks of the 
pitch-blade system, the added cost of the Fibra-Cel disks ultimately may be irrelevant in a 
cost-benefit analysis. 
In summary, the results of this study, detailed in table 1, show that the packed-bed 
bioreactor operated in perfusion mode is superior to the pitched-blade bioreactor operated 
in batch mode for growth of rCHO cells secreting ALKP.  Given the greater productivity 
of cells cultured in the packed-bed bioreactor and the multitude of advantages of this 
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system operated in perfusion mode, researchers desiring to scale up mammalian cell 
culture for protein production should strongly consider this strategy. 
 
The approach used in these experiments can now be modified in a number of 
ways.  While the present experiments utilized a recombinant CHO cell line, many other 
cell lines engineered to secrete proteins can be utilized in similar investigations to 
generalize the utility of the system.  With the development of single use bioreactor 
systems, it is desirable to conduct a comparative study between glass and disposable 
vessels to determine the feasibility of single use bioreactors.  Conducting these 
experiments with a continuous perfusion mode of operation may also be desirable. In this 
model media is constantly removed and replaced with fresh media for the duration of the 
project.  This modified perfusion process could potentially reduce the levels of toxic 
byproducts inside the culture vessel, thereby increasing cell productivity. Repeating these 
experiments in larger scale bioreactors is also important for process optimization and 
design. 
Table 1: Comparison of the Pitched-Blade and Packed-Bed Bioreactors 
 
Pitched-Blade Bioreactor Packed-Bed Bioreactor 
Exp 1 Exp 2 Exp 3 Exp 1 Exp 2 Exp 3 
Starting cell number (10
5
 cells) 
2.9 3.8 5.7 5.0* 5.0* 5.0* 
Highest cell number (10
9
 cells) 
4.59 5.95 3.74 1.36** 0.335** 0.908** 
Duration (h) 
217 215 188 360 363 352 
Maximum protein produced (U/ml) 
3.57 2.47 2.14 5.82 3.79 14.58 
Note. *Counts calculated prior to bioreactor seeding. 
        **Counts calculated from a sample of Fibra-Cel disks removed from the 
bioreactor at the end of the run, Inaccurate. 
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APPENDIX A 
Stirred-Tank Bioreactor preparation as modified from the manufacturer manual of 
operation 
INITIAL PREPERATION OF VESSEL ASSEMBLY 
Clean glass vessel jacket and stainless steel headplate and base.  Use a soft brush or 
sponge, warm tap water and mild cell culture detergent to clean all parts.  Rinse several 
times with tap water until the detergent is removed.  Rinse one final time with distilled 
water and allow vessel to dry. 
Check the integrity of the O-ring at the base of the vessel. Replace O-ring if necessary. 
Siliconize the O-ring at the base of the vessel assembly with food grade Silicon Grease. 
When the O-ring is seated in the O-ring groove, the O ring should extend above the level 
of the metal plate. 
Place the glass vessel on the metal base and secure the bolts by finger tightening until 
the base and vessel are firmly attached to each other.   Do not over tighten as this will 
result in a poor seal and excessive wear on the O-ring. 
BASKET IMPELLER ASSEMBLY 
Before assembling the basket make sure to understand the correct positioning of the 
basket. 
Insert the bottom of the basket into the vessel.  The rubber gasket around the basket 
insert will need to be moistened to assist in pushing the basket to the bottom of the glass 
vessel.  Make sure to keep basket horizontal as pressure is applied on the basket insert.  
Once properly installed make sure bottom basket insert is level to avoid any shearing of 
the impeller against the inner draft tube.  
Fill the basket with Fibra-Cel disks.  100g/L of basket volume is the recommended 
filling density.  The basket volume is about 50% of the working volume.  Vessel to be 
used has a total working volume of 1.7 liters.  85g of Fibra-Cel disks was used. 
Insert the top of the basket into the vessel.  The rubber gasket around the basket insert 
will need to be moistened to assist in pushing the basket into the glass vessel.  Align the 
small and large holes in the top insert with the appropriate stainless steel well tubes in the 
bottom insert. 
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ASSEMBLING THE HEADPLATE 
Check the integrity of the O-ring on the headplate and each port.  Replace any O-rings 
if necessary. 
Siliconize the large O-ring on the headplate with food grade Silicon Grease. 
Place the headplate on the glass vessel allowing the basket impeller to be positioned in 
the central draft tube.  The headplate for the pitch blade system is not restricted in its 
placement. 
Align the headplate on the vessel so that the sampler port is directly above the small 
well in the basket. 
Insert the Harvest tube until it reaches the bottom of the glass vessel and fasten it to the 
headplate.  Attach silicone tubing at the appropriate length to the exposed tube and secure 
with a tie wrap.  The opposite end of the tubing will have an Aseptiquik Connector 
(Colder Products Company) attached to it. 
 
 
 
 
 
 
 
 
 
 
Insert the Thermowell into the headplate.  The thermowell only extends partially down 
the glass vessel, just above the top of the basket.  In the pitch blade system the 
thermowell goes down close to the bottom of the glass vessel. 
Insert the Addition ports into the headplate.   The addition port has three addition tubes. 
In this setup only one of the ports will be used to add base into the system. The other two 
ports will be sealed off by securing a small piece of silicon tubing attached to each of the 
two unused ports.  
       
Figure 19. Aseptiquik connector 
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Insert the Inoculation port into the headplate.  Attach silicone tubing at the appropriate 
length to the exposed tube and secure with a tie wrap.  The opposite end of the tubing 
will have an Aseptiquik Connector (Colder Products Company) attached to it. 
Insert the Sampler port with the attached the valve into the headplate.  Connect the 
sample bottle and rubber bulb.   
Insert the Exhaust Condenser onto the headplate.  The exhaust condenser is secured by 
a ring nut that needs to be finger tightened.  Attach a small piece of silicone tubing to the 
outlet with a 0.2µ filter at the end of the tubing. 
Insert the Sparger port into the headplate.  (Only necessary on the pitch blade system.) 
Insert the Dissolved Oxygen (DO) probe into the headplate.  First check the integrity 
of the DO probe membrane.  Second replace the electrolyte solution inside the DO probe 
that surrounds the sensor.  Lightly wet the DO probe to assist in inserting it into the 
appropriate port in the headplate.  
Plug any remaining ports in the headplate with stainless steel blind stoppers. 
Secure the headplate to the glass vessel by finger tightening the thumb screws a little by 
little.  Tighten the screws in a star pattern and not one at a time in a circular pattern.   Do 
not over tighten as this will result in a poor seal and excessive wear on the O-ring. 
CALIBRATE THE pH PROBE  
Connect the pH probe to the pH connector cable that is connected to the control cabinet. 
Do not twist the cable to prevent damaging it.  After removing the protective red cap on 
the pH probe proceed to turn the probe to make the connection. 
Prepare pH calibration buffers.  Place approximately 15mL of pH 7.0 and 4.0 solutions 
into 50mL tubes. 
Calibrate the ZERO with buffer pH 7.0.  Select the calibration screen on the Bioflo 
310 consol screen and press pH under loops.  Rinse pH probe with distilled water and 
then place it in tube containing pH 7.0 and allow the probe to equilibrate for a few 
minutes.  Touch the SET ZERO edit box and enter 7.0 and press OK.   Press the Set Zero 
button. 
Calibrate the SPAN with buffer pH 4.0.  Rinse pH probe with distilled water and then 
place it in tube containing pH 4.0 and allow the probe to equilibrate for a few minutes. 
Touch the SET SPAN edit box and enter 4.0 and press OK. Press the Set Span button. 
Disconnected pH probe from cable and place red protective cap on the pH probe.  
45 
 
Insert the pH probe into the headplate.  Use CAUTION and wear protective gloves 
when installing probes in case of accidental breakage.  Lightly wet the pH probe to assist 
in inserting it into the appropriate port in the headplate.  
 NOTE: the pH calibration should be checked after autoclaving.  Before 
inoculating, take a sample of media and using an offline pH meter, compare it to 
the pH from the control cabinet.  Adjust any differences with the SET ZERO 
procedure. 
CONNECTING AND DISCONNECTING VESSEL WATER SUPPLY 
 Before proceeding be sure to read and follow these procedures. 
Connecting vessel: 1) Connect vessel Water Out line, 
         2) Connect vessel Water In line, 
         3) Connect Main Water In line, 
         4) Turn ON main power switch on cabinet. 
Disconnecting vessel: 1) Turn OFF main power switch on cabinet, 
              2) Disconnect Main Water In line from cabinet, 
              3) Disconnect vessel Water In line, 
              4) Disconnect vessel Water Out line.  
INSPECTION FOR FUNCTIONALITY BEFORE AUTOCLAVING 
Fill the water jacket with water.   After the water supply has been properly connected 
to the vessel following the Connecting Vessel Water Supply procedure press the 
temperature control loop on the consol screen.  Enter the temperature setpoint at least 
12⁰ C below the current value and turn the temperature control to ON.  The water jacket 
will fill with water. 
Temperature Functionality Test.  Insert the RTD sensor into the thermowell and 
connect the sensor to the appropriate cable on the consol cabinet.  Set the temperature to 
37⁰ C and observe the change in temperature on the control screen. 
Sparging Functionality Test.  Connect the gas line on the consol cabinet to the vessel 
assembly.  On the control screen turn the gas on. Observe bubbles coming from the top of 
the central shaft in the basket bioreactor and the sparger at the bottom of the pitch blade 
bioreactor. 
Agitation Functionality Test.  Attach the motor to the magnetic drive coupling and 
connect the motor to the appropriate connector on the consol cabinet.  Set the agitation to 
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100 RPM and observe the turning of the discharge tubes in the basket bioreactor and the 
turning of the pitch blade in the pitch blade bioreactor. 
Dissolved Oxygen Probe Functionality Test.  Connect the DO probe to the appropriate 
cable on the consol cabinet.  Observe any changes in the Present Value (PV) on the 
control screen. 
PREPARING VESSEL FOR AUTOCLAVE 
Fill the glass vessel with Phosphate Buffer Saline (PBS).  Place a funnel in one of the 
free ports in the headplate and fill glass vessel with PBS.  The amount of PBS depends on 
volume of vessel assembly.  Vessel to be used has a total working volume of 2.0 liters. 
Approximately 1.5 liters of PBS will be used.  
Fill the water jacket half full with water.   After the water supply has been properly 
connected to the vessel following the Connecting Vessel Water Supply procedure press 
the temperature control loop on the consol screen.  Enter the temperature setpoint at least 
12⁰ C below the current value and turn the temperature control to ON.  The jacket will 
then begin to fill with water. Once the jacket is half full, turn the temperature control to 
OFF. 
Disconnect all water lines following the Disconnecting Vessel Water Supply.  Also 
disconnect all other probes, sensors and gas lines from the headplate. 
Cover any filters with tin foil before autoclaving to allow the filters to vent during the 
autoclaving process.  The foil also prevents moisture from clogging them up.  
Secure all tubing with a plastic clamp.  To ensure that the clamps do not fail during 
autoclaving, place a plastic cable tie around the clamp. 
Prior to placing the vessel in the autoclave be sure to loosen the sampling bottle and 
the four thumb screws connecting the headplate to the glass vessel by ½ turn.  This 
allows pressure to equalize and to prevent the glass vessel from breaking during the 
autoclave process. 
Sterilize vessel assembly for 30 minutes after autoclave reached 121⁰ C.  The liquid 
cycle with slow exhaust should be selected on the autoclave.  
Remove vessel assembly from the autoclave using appropriate gloves.  Immediately 
finger tighten the thumb screws and the sample glass bottle.  Allow the vessel assembly 
to cool at room temperature before connecting it to the consol.  
CONDITIONING VESSEL ASSEMBLY FOR INOCULATION 
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Place vessel assembly next to the console cabinet. 
Connect vessel and condenser Water In and Water Out lines following the 
Connecting Vessel Water Supply procedure.  
Connect condenser Water In and Water Out lines following the Connecting Vessel 
Water Supply procedure.  The water line out connects to the quick connect fitting at the 
top of the condenser.  The water in line connects the quick connect fitting at the bottom 
of the condenser.   
Insert the RTD sensor into the thermowell and add ~2mL of distilled water or glycerol 
to the thermowell. 
Fill the vessel jacket with water.  After the water supply has been properly connected to 
the vessel following the Connecting Vessel Water Supply procedure press the 
temperature control loop on the consol screen.  Enter the temperature setpoint to 37⁰ C 
and turn the temperature control to ON.  The jacket will then begin to fill with water to 
slowly cool the vessel assembly. 
Connect the pH probe to the pH probe cable. 
Connect the DO probe to the DO probe cable. 
Attach the motor to the magnetic drive coupling and set the agitation to 100 RPM. 
Connect the gas line to the sparger inlet line on the vessel. 
CALIBRATE THE DO PROBE  
Connect the DO probe to the DO connector cable that is connected to the control 
cabinet. Do not twist the cable to prevent damaging it.  After removing the protective cap 
on the DO probe proceed to connect the cable to the DO probe.  
Calibrate the ZERO.  Select the calibration screen on the Bioflo 310 consol screen and 
press DO under loops.  Disconnect the DO probe from the cable and allow the probe to 
equilibrate for a few seconds.  Touch the SET ZERO edit box and enter 0.0 and press 
OK.  Press the Set Zero button. 
Calibrate the SPAN.  Connect the DO probe the DO probe cable. Select agitation under 
loops and turn the agitation to 100.  Under the gas flow loop, turn on the gas flow and 
exit.  Under the O2 loop, sparge in 100% oxygen and allow medium to mix for a few 
minutes.  Touch the SET SPAN edit box and enter 100 and press OK. Press the Set Span 
button. 
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REMOVE PBS FROM VESSEL  
Turn off the agitation control loop from the consol screen. 
Turn off the gas control loop from the consol screen. 
Turn off the temperature control loop from the consol screen and remove RTD sensor 
from thermowell. 
Pitched-Blade Bioreactor 
Disconnect all cables and tubing from the vessel assembly making sure that all tubing is 
clamped off. 
Under a laminar flow hood, connect harvest port tubing to a peristaltic pump.  Start 
pumping PBS into a collection bag. 
Packed-Bed Bioreactor “Click-Pull-Click” 
Turn off the agitation and gas flow control loops from the control screen. 
Connect the appropriate blue (Waste collection bag) and white (Harvest port) 
AseptiQuik Connectors.  Once properly connected a click sound will be made.  Pull the 
provided tabs from the center of the connected pieces.  Turn the blue and white 
connectors in opposite directions to seal the connection.  Another click sound will be 
made.  Using a peristaltic pump start pumping the PBS from the vessel into the waste 
collection bag. 
 NOTE: Due to the amount of times required to stop the reactor to remove media 
from the packed-bed bioreactor, Aseptiquik  Connectors are used to sterilely 
connect all components to the bioreactor.  With this method there is no need for a 
laminar flow hood when using the packed-bed bioreactor.  
ADDING MEDIUM TO THE VESSEL 
Pitched-Blade Bioreactor 
Under a laminar flow hood, connect the medium addition line to a peristaltic pump. 
Start pumping medium into the vessel. Allow medium to condition to 37⁰ C before 
adding to bioreactor vessel. 
Packed-Bed Bioreactor “Click-Pull-Click” 
Connect the appropriate blue (Media bag) and white (Media addition port) 
AseptiQuik Connectors.  Once properly connected a click sound will be made.  Pull the 
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provided tabs from the center of the connected pieces.  Turn the blue and white 
connectors in opposite directions to seal the connection.  Another click sound will be 
made.  Using a peristaltic pump start pumping media from 10L bag into the bioreactor. 
Allow medium to condition to 37⁰ C before adding to bioreactor vessel. 
INOCULATION 
Pitched-Blade Bioreactor 
Under a laminar flow hood, connect the medium addition line to a peristaltic pump. 
Start pumping medium containing cells into the vessel. 
Reconnect the vessel to the consol and turn on all control loops. 
Measure the pH of a sample of medium.  Take a sample of medium from the vessel to 
an offline calibrated analytical pH meter.  Adjust the pH calibration ZERO point if there 
is a change in the pH reading. 
Packed-Bed Bioreactor “Click-Pull-Click” 
Connect the appropriate blue (Media bottle containing cells) and white (Cell 
addition port) AseptiQuik Connectors.  Once properly connected a click sound will be 
made.  Pull the provided tabs from the center of the connected pieces.  Turn the blue and 
white connectors in opposite directions to seal the connection.  Another click sound will 
be made.  Using a peristaltic pump start pumping the cell suspension from media bottle 
into the bioreactor. 
Turn on the agitation and gas flow control loops.  Set the agitation speed to 40rpm for 
one hour to allow cells sufficient time to accumulate in the Fibra-Cel disk bed.  Increase 
speed to desired level.  
Measure the pH of a sample of medium.  Take a sample of medium from the vessel to 
an offline calibrated analytical pH meter.  Adjust the pH calibration ZERO point if there 
is a change in the pH reading. 
GROWTH CONDITIONS 
Set the temperature setpoint to 37⁰ C under the temperature control loop. 
Set the agitation setpoint to 120 RPM under the agitation control loop. 
Set the pH setpoint to 7.1 under the pH control loop. 
Set the DO setpoint to 35% under the DO control loop 
50 
 
Set the Gas Flow setpoint to 0.5% under the gas flow control loop. 
CULTURE MONITORING 
Take daily samples of media from the vessel assembly using the sampler port. 
Analyze the samples for glucose consumption and lactate production offline using the 
YSI 2700 Select Biochemistry Analyzer. 
Freeze a small sample for later use.  This sample will be used to analyze the amount of 
protein in the media.  The cells in the samples from the pitched-blade bioreactor will be 
used for RNA analysis.  
CELL COUNT AND VIABILITY 
Turn on the countess instrument to display the startup screen.  The countess is preset to 
cell mode.  
Mix 10µL of cells with 10µL of supplied trypan blue stain in a microfuge tube.  
Gently mix the sample by pipetting up and down. 
Add 10µL of the sample mixture to each chamber labeled A and B on the provided 
slide.  Insert the slide, sample chamber A first, into the slide inlet on the instrument then 
press the Count Cells button on the touch screen.   The image may be adjusted using the 
Zoom button and quadrants can be viewed using the grid.  The image can also be fine 
tuned using the focus knob on the instrument. 
 NOTE: Accurate cell counts will not be taken in the packed-bed bioreactor due to 
the lack of cells in sample. 
INDUCION OF PITCHED-BLADE BIOREACTOR 
Connect the appropriate blue (Media bottle with IPTG) and white (Addition port) 
AseptiQuik Connectors.  Once properly connected a click sound will be made.  Pull the 
provided tabs from the center of the connected pieces.  Turn the blue and white 
connectors in opposite directions to seal the connection.  Another click sound will be 
made.  Using a peristaltic pump start pumping IPTG into the bioreactor.  Allow medium 
to condition to 37⁰ C before adding to bioreactor vessel. 
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PERFUSION AND INDUCTION OF PACKED-BED BASKET BIOREACTOR 
Start the perfusion 2-3 days post inoculation by removing 0.5L of media from the 
vessel. Immediately replace with 0.5L of fresh media.  
On day two of perfusion, remove 1L of media from the vessel.  Immediately replace 
with 1L of fresh media.  Allow medium to condition to 37⁰ C before adding to bioreactor 
vessel. 
Add IPTG to remaining media in 10L bag.  Once the second perfusion has been 
performed add the appropriate amount of IPTG to the remaining media.  Use the second 
Aseptiquik Connector attached to the media bag, connect it to a media bottle containing 
the IPTG. Pump IPTG into the media bag.  
On day three of perfusion, remove the complete contents of the vessel.  Immediately 
replace with media that contains IPTG in fresh media. 
On days four through fifteen of perfusion, media will be removed every other day to 
allow for a longer run time.  
 NOTE: The packed-bed basket assembly allows for complete medium exchange 
without the loss of any cell mass. 
SHUT DOWN 
Pitched-Blade Bioreactor.  Once the viability in the bioreactor falls below 50% turn off 
all control loops on the console. 
Immediately after shut down start to clean all parts of the bioreactor.  Add bleach or 
CiDecon to the cell suspension to kill the cell mass.  Using soap, clean all parts of the 
headplate and vessel and flush all addition, harvest and sample ports with hot water. 
Packed-Bed Bioreactor. On day 15 after analyzing the media sample remove the media 
in the vessel.  
Take the vessel under the laminar flow hood and remove a small sample of disks and 
weight them for later use.  Weight out the remaining disks in the bioreactor for a total 
weight of the disks.  
Immediately start to clean all parts of the bioreactor. Add bleach or CiDecon to the 
vessel to kill any cells that remain.  Using soap, clean all parts of the headplate and vessel 
and flush all addition, harvest and sample ports with hot water. 
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APPENDIX B 
Freeze & Thaw Cells 
 Modified from the manufacturer Protocol 
Equipment: 
Laminar Flow Hood such as BioGARD Hood, model B60-112, The Baker 
Company, Sanford ME 04073. 
Centrifuge such as Eppendorf Centrifuge, model 5804R, Eppendorf, Enfield CT, 
06082. 
Automated Cell Counter such as Countess Automated Cell Counter, Invitrogen, 
Grand Island, NY 14072. 
Incubator such as CO2 Incubator, model HERAcell model 150i, Thermo 
Scientific, Asheville, NC 28801. 
Water bath such as Dual Chamber Water Bath, model 188, Precision Scientific, 
Chicago, IL 60647. 
Pipeteman such as Pipetman Classic, model p20, p200 and p1000, Gilson, Inc., 
Middleton, WI 53562.  
Pipet-Aid such as Labnet FastPette , Labnet International, Inc., Woodbridge 
 NJ, 07095. 
Nitrogen Tank such as Thermolyne, model Locator 4, Barnstead International, 
Dubuque IA, 52004. 
-80°C Freezer such as Isotemp basic, Model U86-25D2, Thermo Fisher, Asheville 
NC, 28801. 
Supplies: 
 Permanent marker 
50 mL conical tubes 
Cryovials 
T-75 Flasks 
70% Ethanol 
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Gloves 
Kimwipes  
DMSO 
Freezing container 
Pipets (10 mL & 25 mL) 
Pipet tips (10 – 1000 µl)  
CD-CHO Medium (1000 mL) 
 -from Gibco, Grand Island, NY 14072 
 -cat. # 10743029 
L-Glutamine 
 -Mediatech Inc. Glutamine 200MM 
 -cat. # MT25005LI 
Antibiotic-Antimycotic 
 -Mediatech Inc. cellgro > 100mL 
 -cat. # MT-30-004-CI 
Countess Cell Counting Chamber Slides 
  - Invitrogen, Grand Island, NY 14072 
  -cat # C10228 
Procedures: 
1.  Thaw PACE CHO-KS Cell Line 
a.   Cells are supplied at 1 X 10
7
 cells per vial in 10% DMSO in CD CHO 
medium. 
 b.   Store cells in liquid nitrogen until ready to thaw. 
 c.   Thaw cryovial in a 37°C water bath for 2 min. 
d.   Pipet out cells in 0.5 mL CD CHO medium into 10  mL total CD CHO (to      
remove trace amounts of DMSO). 
e.   Centrifuge cells for 3 minutes at 1200 rpm at room temperature. 
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f.   Aspirate supernatant above the pellet. 
g.   Resuspend pellet in 25 mL of CD CHO medium. 
h.   Transfer cells to a t-75 flask in a 37°C incubator, 5% CO2. 
i.   Passage a minimum of twice before use. 
2. Freeze PACE CHO-KS Cell Line 
a.   Cells are grown to a density of approximately 1 x 10
6
 cells/mL. Viability 
should be at least 90%. 
b.   Centrifuge cells at 1,200 rpm for 3 min at room temperature and carefully 
aspirate medium. 
c.   Resuspend cells in cell freezing medium to obtain the final density of 1 X 10
7 
viable cells/mL. 
d.   Aliquot 1 mL of the cell suspension into each cryovial. 
e.  Transfer vials to -80°C freezer. Frozen vials are transferred to liquid nitrogen 
for long-tern storage. 
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APPENDIX C 
SensoLyte pNPP Secreted Alkaline Phosphatase Reporter Gene Assay 
Modified from the manufacturer Protocol 
(With permission from AnaSpec) 
Equipment: 
Laminar Flow Hood such as BioGARD Hood, model B60-112, The Baker 
Company, Sanford, ME 04073. 
Incubator such as CO2 Incubator, model HERAcell model 150i, Thermo 
Scientific. Asheville, NC 28801. 
 
Water bath such as Dual Chamber Water Bath, model 188, Precision Scientific, 
Chicago, IL 60647. 
Pipeteman such as Pipetman Classic, models p20, p200 and p1000, Gilson, Inc., 
Middleton, WI 53562.  
Pipeteman such as Fisherbrand, model Finnpipette-12 50-300µl, Thermo 
Scientific, Asheville, NC  28801. 
 
Absorbance Microplate Reader such as SpectraMax Plus, model 384, Molecular 
Devices, Sunnyvale, CA 94089. 
 
Supplies: 
 Permanent marker 
70% Ethanol 
Gloves 
Kimwipes  
96-Well plate 
PBS 
Pipet tips (10 – 1000 µl)  
Sterile Disposable Reagent Reservoirs  
56 
 
SensoLyte pNPP Secreted Alkaline Phosphatase Reporter Gene Assay Kit 
  - AnaSpec, Freemont, CA 94555 
-Kit Size 500 Assays (96-well) 
  -cat # 71233 
   Component Description                Quantity 
   Component A: pNPP, Placental alkaline phosphatase 1 vial 
   Component B: 2X Assay buffer    30 mL 
   Component C: Stop Solution (Optional)   30 mL 
  
INTRODUCTION 
The placental alkaline phosphatase is the most stable isoenzyme among the four 
mammalian alkaline phosphatases and it only exists naturally in the placenta of higher 
primates.  These characteristics make placental alkaline phosphatase the enzyme of 
choice to serve as a reporter gene for the analysis of promoter activity and gene 
expression in cell culture or animals.  The natural form of placental alkaline phosphatase 
is membrane-anchored.  The recombinant form of placental alkaline phosphatase is the 
secreted alkaline phosphatase (SEAP).
1,2
 
The SensoLyte® pNPP Secreted Alkaline Phosphatase Reporter Gene Assay Kit 
provides a convenient colorimetric assay of placental alkaline phosphatase for both 
secreted and membrane-bound forms by using pNPP as a phosphatase substrate.  The 
absorbance signal can be read at 405 nm. 
 
References 
1.  Berger, J., J. Hauber, R. Hauber, R. Geiger, B. R. Cullen, Secreted placental 
alkaline phosphatase: a powerful new quantitative indicator of gene expression in 
eukaryotic cells. Gene 66, 1988:  p. 1-10. 
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2.  Cullen, B. R. and M. H. Malim, Secreted alkaline phosphatase as an eukaryotic 
reporter gene. Methods Enzymol, 1992: p. 216, 362-368. 
Procedures: 
1. Prepare placental alkaline phosphatase containing sample. 
1.1 Collect the supernatant of cell culture medium. 
 Note: the supernatant can be stored at -70ºC for later use. 
1.2 Heat the culture supernatant at 65ºC for 10-30 min to inactivate the 
endogenous non-specific alkaline phosphatase.  Then cool down to room 
temperature. 
 
2. Prepare stock solution (first time preparation only). 
2.1 pNPP stock solution: Reconstitute by adding 250 µL of deionized water 
into the pNPP vial (Component A). Mix the reagents well.  The stock 
solution will be good for 3-4 weeks if stored at -20ºc. 
 
3. Prepare pNPP reaction mixture. 
 
3.1 Dilute pNPP stock solution 1:100 with 2X assay buffer (Component B). 
Prepare fresh reaction mixture for each experiment. 
 
4. Start the placental alkaline phosphatase detection. 
 
4.1 Add 50 µL/well of supernatant or cell extract. Include a mock-supernatant 
(such as PBS) to serve as a negative control 
 
4.2 add 50 µL/well of pNPP reaction mixture. Mix the reagents by gently 
shaking the plate for 30 sec. 
 
4.3 Measure absorbance: 
 
For kinetic reading: Immediately start measuring absorbance at 
405 nm continuously and record data every 5 min for 30-60 min. 
 
For end-point reading: Incubate the reaction for 30-60 min. 
Optional: add 50 µL/well of stop solution (Component C).  Shake 
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the plate on a plate shaker for 1 min before the reading.  Measure 
absorbance at 405 nm. 
 
Note: If the amount of SEAP is low in the sample, the incubate 
time can be prolonged to overnight. 
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APPENDIX D 
Miscellaneous Equipment Used 
  
                           
Figure 21.  The YSI 2700 Select biochemistry analyzer. 
 
Figure 22.  The Countess instrument, an automated cell counter. 
       
Figure 20.  Disposable spinner flasks. (Left) 500 mL, (Right) 125 mL.  
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Figure 23. AseptiQuik connector (Colder Products, Part 
# AQC17006HT & AQC22006HT). Allowed for sterile 
connections of tubing without the need for laminar flow 
hood. 
    
Figure 24.  (A) Packed-bed basket bioreactor. (B) 
Pitched-blade bioreactor connected to the BioFlo 310 
console. 
